Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Mebazaa

Showing results (631-640 of 645) with videos related to

Pageof 65
Sort By:
The Lancet. Digital Health|September 3, 2022
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort studyJan A Staessen, Ralph Wendt, Yu-Ling Yu, et al.
European Heart Journal|October 9, 2018
Treatments targeting inotropyChristoph Maack, Thomas Eschenhagen, Nazha Hamdani, et al.
European Journal of Heart Failure|June 22, 2013
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus documentFaiez Zannad, Angeles Alonso Garcia, Stefan D Anker, et al.
European Journal of Heart Failure|July 14, 2023
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESCMarco Metra, Marianna Adamo, Daniela Tomasoni, et al.
Heart Failure Reviews|February 12, 2025
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysisBeth A Davison, Antonio Abbate, Gad Cotter, et al.
Annals of Intensive Care|January 29, 2021
Current use of inotropes in circulatory shockThomas W L Scheeren, Jan Bakker, Thomas Kaufmann, et al.
Circulation. Heart Failure|August 30, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 TrialKristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Daniel Modin, et al.
European Heart Journal|April 9, 2019
The continuous heart failure spectrum: moving beyond an ejection fraction classificationFilippos Triposkiadis, Javed Butler, Francois M Abboud, et al.
Journal of Cardiovascular Pharmacology|July 9, 2020
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.
European Journal of Heart Failure|January 25, 2024
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)Wilfried Mullens, Jeroen Dauw, Finn Gustafsson, et al.
Pageof 65

Showing results (631-640 of 645) with videos related to

Sort By:
Pageof 65
The Lancet. Digital Health|September 3, 2022
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort studyJan A Staessen, Ralph Wendt, Yu-Ling Yu, et al.
European Heart Journal|October 9, 2018
Treatments targeting inotropyChristoph Maack, Thomas Eschenhagen, Nazha Hamdani, et al.
European Journal of Heart Failure|June 22, 2013
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus documentFaiez Zannad, Angeles Alonso Garcia, Stefan D Anker, et al.
European Journal of Heart Failure|July 14, 2023
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESCMarco Metra, Marianna Adamo, Daniela Tomasoni, et al.
Heart Failure Reviews|February 12, 2025
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysisBeth A Davison, Antonio Abbate, Gad Cotter, et al.
Annals of Intensive Care|January 29, 2021
Current use of inotropes in circulatory shockThomas W L Scheeren, Jan Bakker, Thomas Kaufmann, et al.
Circulation. Heart Failure|August 30, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 TrialKristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Daniel Modin, et al.
European Heart Journal|April 9, 2019
The continuous heart failure spectrum: moving beyond an ejection fraction classificationFilippos Triposkiadis, Javed Butler, Francois M Abboud, et al.
Journal of Cardiovascular Pharmacology|July 9, 2020
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.
European Journal of Heart Failure|January 25, 2024
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)Wilfried Mullens, Jeroen Dauw, Finn Gustafsson, et al.
Pageof 65